Viral interference with MHC class I antigen presentation pathway: The battle continues

被引:43
作者
Ambagala, APN
Solheim, JC
Srikumaran, S
机构
[1] Univ Nebraska, Dept Vet & Biomed Sci, Lincoln, NE 68583 USA
[2] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
关键词
virus; antigen presentation; MHC class I; evasion; review;
D O I
10.1016/j.vetimm.2005.04.006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD8(+) cytotoxic T lymphocytes (CTLs) play a critical role in the defense against viral infections. In general, CD8(+) CTLs recognize antigenic peptides in the context of the major histocompatibility complex (MHC) class I molecule. The MHC class I molecules are expressed on almost all the nucleated cells in the body. The trimolecular complex consisting of the class I heavy chain, beta 2-microglobulin and the peptide are generated by the MHC class I antigen presentation pathway. This pathway is designed to sample the intracellular milieu and present the information to the CTLs trafficking the area. This rigorous sampling of intracellular environment enables the CTLs to quickly identify and eliminate the cells that synthesize non-self proteins as a result of a viral infection. Many viruses, including several viruses of veterinary importance, have evolved astounding strategies to interfere with the MHC class I antigen presentation pathway, as a means of evading the CTL response of the host. This review focuses on the diverse mechanisms of viral evasion of the MHC class I antigen presentation pathway with particular emphasis on viruses of veterinary importance. (C) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 143 条
  • [1] Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells
    Abendroth, A
    Lin, I
    Slobedman, B
    Ploegh, H
    Arvin, AM
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (10) : 4878 - 4888
  • [2] The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
    Ahn, K
    Gruhler, A
    Galocha, B
    Jones, TR
    Wiertz, EJHJ
    Ploegh, HL
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. IMMUNITY, 1997, 6 (05) : 613 - 621
  • [3] Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47
    Ahn, K
    Meyer, TH
    Uebel, S
    Sempe, P
    Djaballah, H
    Yang, Y
    Peterson, PA
    Fruh, K
    Tampe, R
    [J]. EMBO JOURNAL, 1996, 15 (13) : 3247 - 3255
  • [4] Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
    Ahn, KS
    Angulo, A
    Ghazal, P
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10990 - 10995
  • [5] Peptide transport activity of the transporter associated with antigen processing (TAP) is inhibited by an early protein of equine herpesvirus-1
    Ambagala, APN
    Gopinath, RS
    Srikumaran, S
    [J]. JOURNAL OF GENERAL VIROLOGY, 2004, 85 : 349 - 353
  • [6] An early pseudorabies virus protein down-regulates porcine MHC class I expression by inhibition of transporter associated with antigen processing (TAP)
    Ambagala, APN
    Hinkley, S
    Srikumaran, S
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (01) : 93 - 99
  • [7] IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE
    ANDERSSON, M
    PAABO, S
    NILSSON, T
    PETERSON, PA
    [J]. CELL, 1985, 43 (01) : 215 - 222
  • [8] CHARACTERISTICS OF PEPTIDE AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I BETA(2)-MICROGLOBULIN BINDING TO THE TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING (TAP1 AND TAP2)
    ANDROLEWICZ, MJ
    ORTMANN, B
    VANENDERT, PM
    SPIES, T
    CRESSWELL, P
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) : 12716 - 12720
  • [9] Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal α and β subunits
    Apcher, GS
    Heink, S
    Zantopf, D
    Kloetzel, PM
    Schmid, HP
    Mayer, RJ
    Krüger, E
    [J]. FEBS LETTERS, 2003, 553 (1-2) : 200 - 204
  • [10] Ashrafi GH, 2002, ONCOGENE, V21, P248